143 related articles for article (PubMed ID: 17239935)
21. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
22. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.
Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.
Kipp BR; Tyner HL; Campion MB; Voss JS; Karnes RJ; Sebo TJ; Halling KC; Zhang J
Am J Clin Pathol; 2008 Oct; 130(4):552-9. PubMed ID: 18794047
[TBL] [Abstract][Full Text] [Related]
25. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
26. Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population.
Rygiel AM; van Baal JW; Milano F; Wang KK; ten Kate FJ; Fockens P; Rosmolen WD; Bergman JJ; Peppelenbosch MP; Krishnadath KK
Cancer; 2007 May; 109(10):1980-8. PubMed ID: 17385213
[TBL] [Abstract][Full Text] [Related]
27. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
28. Primary sclerosing cholangitis: role of extrahepatic biliary resection.
Pawlik TM; Olbrecht VA; Pitt HA; Gleisner AL; Choti MA; Schulick RD; Cameron JL
J Am Coll Surg; 2008 May; 206(5):822-30; discussion 830-2. PubMed ID: 18471705
[TBL] [Abstract][Full Text] [Related]
29. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
Furmanczyk PS; Grieco VS; Agoff SN
Am J Clin Pathol; 2005 Sep; 124(3):355-60. PubMed ID: 16191503
[TBL] [Abstract][Full Text] [Related]
30. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.
Karrar A; Broomé U; Södergren T; Jaksch M; Bergquist A; Björnstedt M; Sumitran-Holgersson S
Gastroenterology; 2007 Apr; 132(4):1504-14. PubMed ID: 17408653
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.
Scheid JF; Rosenbaum MW; Przybyszewski EM; Krishnan K; Forcione DG; Iafrate AJ; Staller KD; Misdraji J; Lennerz JK; Pitman MB; Pratt DS
Cancer Cytopathol; 2022 Mar; 130(3):215-230. PubMed ID: 34726838
[TBL] [Abstract][Full Text] [Related]
32. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
33. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
[TBL] [Abstract][Full Text] [Related]
34. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
[TBL] [Abstract][Full Text] [Related]
35. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma.
Taniai M; Higuchi H; Burgart LJ; Gores GJ
Gastroenterology; 2002 Oct; 123(4):1090-8. PubMed ID: 12360471
[TBL] [Abstract][Full Text] [Related]
36. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.
Buckles DC; Lindor KD; Larusso NF; Petrovic LM; Gores GJ
Am J Gastroenterol; 2002 May; 97(5):1138-42. PubMed ID: 12014717
[TBL] [Abstract][Full Text] [Related]
37. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
[TBL] [Abstract][Full Text] [Related]
38. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
39. Detection of numerical abnormalities of chromosome 9 and p16/CDKN2A gene alterations in ovarian cancer with fish analysis.
Aravidis C; Panani AD; Kosmaidou Z; Thomakos N; Rodolakis A; Antsaklis A
Anticancer Res; 2012 Dec; 32(12):5309-13. PubMed ID: 23225431
[TBL] [Abstract][Full Text] [Related]
40. Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study.
Dessy E; Rossi E; Berenzi A; Tironi A; Benetti A; Grigolato P
Histopathology; 2008 Mar; 52(4):475-82. PubMed ID: 18315600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
